Court rules companies can't import Gilead medications from overseas in blow to AFP health programs

· cnbc.com

A U.S. appeals court has ruled in favor of Gilead Sciences against companies known as alternative funding programs that import medicines from overseas.

A court ruling this week in favor of Gilead Sciences could significantly impact a burgeoning class of health programs in the U.S. that federal authorities say a...


Read on WOBR AI → · More AI market news · StrategyVerse · Quant Research · WOBR.AI